13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001009258
申报总市值
US$95.9亿
US$95.9亿
433 檔
24.4%
根据最新整理的 13F 季度数据集，Deerfield Management Company, L.p. 于 Q2 2024 结束时的管理资产规模为 US$95.9亿。该机构在本季度申报了 433 档美股持仓，呈现出该时期的主要投资地图。
在 Q2 2024，Deerfield Management Company, L.p. 操作展现出积极扩展与加仓意向。本季共新建仓 10 个新仓位，并对 17 个既有持股进行加仓（合计增持 27 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Deerfield Management Company, L.p. 的前 5 大核心持股（包含 NUVL, INSM 1.75 01-15-25, VTRS 等）合计占整体申报市值的 24.4%，反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
WAY
市值: US$1.1亿
本季最大获利了结 / 清仓标的
FUSION PHARMACEUTICALS INC
前期市值: US$1.4亿
仅显示前 200 大持股（共 433 只）
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVL | Nuvalent Inc-a | 股票-其他 | 25.23% | +1.37% | — | |
| 2 | INSM 1.75 01-15-25债券 | Insmed Inc | 债券 | 4.30% | — | +29.46% | |
| 3 | VTRS | Viatris Inc | 股票-医疗保健 | 3.78% | +0.13% | +0.00% | |
| 4 | CNC | Centene CORP | 股票-医疗保健 | 2.92% | +0.99% | +11.30% | |
| 5 | IART 0.5 08-15-25债券 | Integra Lifesciences Hld | 债券 | 2.74% | — | +68.93% | |
| 6 | BKD 2 10-15-26债券 | Brookdale Senior Living | 债券 | 2.72% | — | — | |
| 7 | ✓ | Merus N V | 股票-其他 | 2.71% | — | +3.77% | |
| 8 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 2.56% | -0.76% | — | |
| 9 | CPRX | Catalyst Pharmaceuticals Inc | 股票-医疗保健 | 2.35% | -1.15% | EXIT | |
| 10 | AHCO | Adapthealth CORP | 股票-其他 | 2.21% | -0.36% | — | |
| 11 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 2.00% | +2.03% | — | |
| 12 | ACCD 0.5 04-01-26债券 | Accolade Inc | 债券 | 1.92% | — | — | |
| 13 | SGRY | Surgery Partners Inc | 股票-其他 | 1.86% | — | +47.71% | |
| 14 | KURA | Kura Oncology Inc | 股票-其他 | 1.85% | — | — | |
| 15 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 1.83% | — | -25.75% | |
| 16 | BKD | Brookdale Senior Living Inc | 股票-其他 | 1.77% | +0.07% | — | |
| 17 | WAY | Waystar Holding CORP | 股票-其他 | 1.77% | — | — | |
| 18 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 1.70% | — | — | |
| 19 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.58% | -0.95% | EXIT | |
| 20 | SPRY | Ars Pharmaceuticals Inc | 股票-其他 | 1.57% | -0.08% | — | |
| 21 | MIRM 4 05-01-29债券 | Mirum Pharmaceuticals | 债券 | 1.56% | -2.47% | EXIT | |
| 22 | ACH | Accendra Health Inc | 股票-其他 | 1.43% | — | +30.63% | |
| 23 | ALHC | Alignment Healthcare Inc | 股票-其他 | 1.42% | — | +31.81% | |
| 24 | IDYA | Ideaya Biosciences Inc | 股票-其他 | 1.23% | +0.46% | -20.27% | |
| 25 | ✓ | Hillevax Inc | 股票-其他 | 0.96% | — | — | |
| 26 | CVS | Cvs Health CORP | 股票-医疗保健 | 0.96% | — | — | |
| 27 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 0.95% | -0.06% | EXIT | |
| 28 | BAX | Baxter International Inc | 股票-医疗保健 | 0.88% | — | +25590.39% | |
| 29 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.86% | — | — | |
| 30 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.84% | -0.12% | +62.88% | |
| 31 | BNTX | Biontech Se-adr | 股票-其他 | 0.79% | — | +4.29% | |
| 32 | IRON | Disc Medicine Inc | 股票-其他 | 0.77% | — | +53.75% | |
| 33 | EHABUSD | Enhabit Inc | 股票-其他 | 0.74% | -0.79% | EXIT | |
| 34 | CNMD | Conmed CORP | 股票-其他 | 0.73% | — | +86.67% | |
| 35 | IART | Integra Lifesciences Holding | 股票-其他 | 0.71% | — | -0.37% | |
| 36 | BIO | Bio-rad Laboratories-a | 股票-医疗保健 | 0.69% | -0.05% | -0.44% | |
| 37 | DAWNGBX | Day One Biopharmaceuticals I | 股票-其他 | 0.67% | -0.94% | EXIT | |
| 38 | LKFT | Lakefront Biotherapeutic-adr | 股票-其他 | 0.58% | — | — | |
| 39 | EMBC | Embecta CORP | 股票-医疗保健 | 0.57% | -0.17% | — | |
| 40 | GPCR | Structure Therapeutics Inc | 股票-其他 | 0.55% | +0.17% | -18.31% | |
| 41 | COGT | Cogent Biosciences Inc | 股票-其他 | 0.53% | -2.09% | +144.03% | |
| 42 | LNTH 2.625 12-15-27债券 | Lantheus Holdings Inc | 债券 | 0.52% | — | — | |
| 43 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 0.48% | -0.06% | — | |
| 44 | CATX | Perspective Therapeutics Inc | 股票-其他 | 0.47% | — | — | |
| 45 | PHVS | Pharvaris N.V. | 股票-其他 | 0.44% | +0.18% | +31.62% | |
| 46 | MREO | Mereo Biopharma Group Pl-adr | 股票-其他 | 0.40% | — | — | |
| 47 | PODD | Insulet CORP | 股票-医疗保健 | 0.38% | — | +2.16% | |
| 48 | NKTX | Nkarta Inc | 股票-其他 | 0.37% | — | -26.86% | |
| 49 | DCGO | Docgo Inc | 股票-其他 | 0.37% | — | +40.98% | |
| 50 | INMD | InMode Ltd. | 股票-其他 | 0.35% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | INSM 1.75 01-15-25债券 | Insmed Inc | +2.1% | +29.46% | 加仓 |
| 2 | WAY | Waystar Holding CORP | +1.8% | NEW | 新建仓 |
| 3 | GILD | Gilead Sciences Inc | +1.7% | NEW | 新建仓 |
| 4 | MIRM 4 05-01-29债券 | Mirum Pharmaceuticals | +1.6% | NEW | 新建仓 |
| 5 | IART 0.5 08-15-25债券 | Integra Lifesciences Hld | +1% | +68.93% | 加仓 |
| 6 | CVS | Cvs Health CORP | +1% | NEW | 新建仓 |
| 7 | BAX | Baxter International Inc | +0.9% | +25590.39% | 加仓 |
| 8 | ALHC | Alignment Healthcare Inc | +0.7% | +31.81% | 加仓 |
| 9 | ✓ | Merus N V | +0.6% | +3.77% | 加仓 |
| 10 | CGEM | Cullinan Therapeutics Inc | +0.6% | +188.11% | 加仓 |
| 11 | ALNY | Alnylam Pharmaceuticals Inc | +0.5% | NEW | 新建仓 |
| 12 | CATX | Perspective Therapeutics Inc | +0.5% | NEW | 新建仓 |
| 13 | BCRX | Biocryst Pharmaceuticals Inc | +0.4% | +62.88% | 加仓 |
| 14 | MREO | Mereo Biopharma Group Pl-adr | +0.4% | NEW | 新建仓 |
| 15 | COGT | Cogent Biosciences Inc | +0.4% | +144.03% | 加仓 |
| 16 | PACS | Pacs Group Inc | +0.3% | NEW | 新建仓 |
| 17 | RVMD | Revolution Medicines Inc | +0.3% | — | 不变 |
| 18 | CNMD | Conmed CORP | +0.3% | +86.67% | 加仓 |
| 19 | FHTX | Foghorn Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 20 | SGRY | Surgery Partners Inc | +0.2% | +47.71% | 加仓 |
| 21 | TXG | 10x Genomics Inc-class A | +0.2% | NEW | 新建仓 |
| 22 | CGON | Cg Oncology Inc | +0.2% | +811.95% | 加仓 |
| 23 | DAWNGBX | Day One Biopharmaceuticals I | +0.2% | +65.59% | 加仓 |
| 24 | AUTL | Autolus Therapeutics PLC | -0.2% | — | 不变 |
| 25 | LKFT | Lakefront Biotherapeutic-adr | -0.2% | — | 不变 |
| 26 | ACCDUSD | Accolade Inc | -0.2% | +45.88% | 加仓 |
| 27 | GPCR | Structure Therapeutics Inc | -0.2% | -18.31% | 减仓 |
| 28 | BIO | Bio-rad Laboratories-a | -0.2% | -0.44% | 减仓 |
| 29 | ✓ | Engene Holdings Inc | -0.2% | EXIT | 清仓 |
| 30 | EHABUSD | Enhabit Inc | -0.3% | — | 不变 |
| 31 | GH | Guardant Health Inc | -0.3% | EXIT | 清仓 |
| 32 | QDEL | Quidelortho CORP | -0.3% | EXIT | 清仓 |
| 33 | CABA | Cabaletta Bio Inc | -0.3% | -63.12% | 减仓 |
| 34 | VSTM | Verastem Inc | -0.3% | EXIT | 清仓 |
| 35 | CNC | Centene CORP | -0.3% | +11.30% | 加仓 |
| 36 | SLDB | Solid Biosciences Inc | -0.4% | -22.87% | 减仓 |
| 37 | KYTX | Kyverna Therapeutics Inc | -0.4% | +35.60% | 加仓 |
| 38 | SPRY | Ars Pharmaceuticals Inc | -0.4% | — | 不变 |
| 39 | AHCO | Adapthealth CORP | -0.4% | — | 不变 |
| 40 | ISREUR | Isoray Inc | -0.6% | EXIT | 清仓 |
| 41 | OSCR | Oscar Health Inc - Class A | -0.6% | -25.75% | 减仓 |
| 42 | NKTX | Nkarta Inc | -0.6% | -26.86% | 减仓 |
| 43 | VKTX | Viking Therapeutics Inc | -0.7% | EXIT | 清仓 |
| 44 | VTRS | Viatris Inc | -0.7% | +0.00% | 加仓 |
| 45 | IDYA | Ideaya Biosciences Inc | -0.8% | -20.27% | 减仓 |
| 46 | NUVL | Nuvalent Inc-a | -0.9% | — | 不变 |
| 47 | ACH | Accendra Health Inc | -0.9% | +30.63% | 加仓 |
| 48 | SWTXUSD | Springworks Therapeutics Inc | -1.1% | EXIT | 清仓 |
| 49 | DCPHEUR | Deciphera Pharmaceuticals In | -1.4% | EXIT | 清仓 |
| 50 | ✓ | Fusion Pharmaceuticals Inc | -2.4% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Deerfield Management Company, L.p. 在 Q2 2024 季度的美股持仓总市值约为 US$95.9亿，共申报了 433 个公开持股仓位。
在 Q2 2024 季度，Deerfield Management Company, L.p. 按市值排列的前三大核心持股分别为：NUVL (25.2%)、INSM 1.75 01-15-25 (4.3%)、VTRS (3.8%)。其中最大持股仓位 NUVL 占据整体投资组合约 25.2% 的权重。
在 Q2 2024 季度中，Deerfield Management Company, L.p. 共进行了 43 项持仓异动，包含新建仓 10 个仓位、加仓 17 个仓位、减仓 7 个仓位以及清仓 9 个仓位。 其中最大新建仓标的为 WAY。 本季清仓仓位包含 FUSION PHARMACEUTICALS INC。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。